In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th
A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth... (more story)
Del. Forum Selection Clause Sinks IQVIA's NC Poaching Suit
IQVIA Holdings Inc. should have brought its poaching suit against four former employees accused of defecting to a competitor in Delaware court under a forum selection clause in their employment contracts, a No... (more story)
Taxation With Representation: Milbank, De Brauw, Wachtell
In this week's Taxation With Representation, EQT Private Equity announces a takeover offer for life sciences testing company Qiagen NV, Salesforce acquires customer engagement platform Braze and London Stock E... (more story)
FTC Wants More Info On Curium's $8B Deal For Lantheus
The Federal Trade Commission has requested additional information about Curium's planned $8 billion acquisition of fellow radiopharmaceutical company Lantheus Holdings Inc., extending a waiting period that pre... (more story)
Imperative Gets PTAB To Trim Inari Medical Device Claims
The Patent Trial and Appeal Board has invalidated claims in an Inari Medical Inc. patent on valves used in surgery to prevent blood loss, handing another win to challenger Imperative Care as it fends off an in... (more story)
Wachtell Lipton Guides Abbott Nutrition Spinoff
Wachtell Lipton Rosen & Katz guided healthcare company Abbott in a plan to spin off its nutrition business into an independent, publicly traded company anchored by brands such as adult supplement Ensure and in... (more story)